<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.jnutbio.com//inpress?rss=yes"><title>The Journal of Nutritional Biochemistry - Articles in Press</title><description>The Journal of Nutritional Biochemistry RSS feed: Articles in Press. Devoted to advancements in nutritional sciences, the  The Journal of Nutritional Biochemistry  presents experimental nutrition 
research as it relates to: biochemistry, neurochemistry, molecular biology, toxicology, physiology and pharmacology. Rigorous reviews 
by an international editorial board of distinguished scientists ensure publication of the most current and key research being conducted 
in nutrition at the cellular, animal and human level. In addition to its monthly features of critical reviews and research communications, 
the  The Journal of Nutritional Biochemistry  also periodically publishes emerging issues, conference summaries, experimental 
methods, symposium reports, metabolic pathways, and short communications.</description><link>http://www.jnutbio.com//inpress?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2010 Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:issn>0955-2863</prism:issn><prism:publicationDate>2010-02-08</prism:publicationDate><prism:copyright> © 2010 Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002071/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002095/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002204/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002034/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002058/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002150/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002162/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002216/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528630900223X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001910/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528630900165X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001727/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001739/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001806/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001909/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002083/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001326/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001636/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001648/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001661/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001673/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001697/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001703/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001715/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001740/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001752/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001764/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001776/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001788/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528630900179X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001922/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001934/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528630900151X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001405/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001508/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001521/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001375/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001399/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001685/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001211/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001338/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001314/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309000862/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001156/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001181/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309000898/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309000989/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309000990/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001004/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001041/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002071/abstract?rss=yes"><title>Different mechanisms of cis-9,trans-11- and trans-10,cis-12- conjugated linoleic acid affecting lipid metabolism in 3T3-L1 cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002071/abstract?rss=yes</link><description>Abstract: Conjugated linoleic acid (CLA) has been shown to reduce body fat mass in various experimental animals. It is valuable to identify its influence on enzymes involved in energy expenditure, apoptosis, fatty acid oxidation and lipolysis. We investigated isomer-specific effects of high dose, long treatment of CLA (75.4 μmol/L, 8 days) on protein and gene expression of these enzymes in cultured 3T3-L1 cells. Proteomics identified significant up- or down-regulation of 52 proteins by either CLA isomer. Protein and gene expression of uncoupling protein (UCP) 1, UCP3, perilipin and peroxisome proliferator-activated receptor (PPAR) α increased whereas UCP2 reduced for both CLA isomers. And eight-day treatment of trans-10,cis-12 CLA, but not cis-9,trans-11 CLA, significantly up-regulated protein and mRNA levels of PKA (P&lt;.05), CPT-1 and TNF-α (P&lt;.01). Compared to protein expression, both isomers did not significantly influence the mRNA expression of HSL, ATGL, ACO and leptin. In conclusion, high-dose, long treatment of cis-9,trans-11 CLA did not promote apoptosis, fatty acid oxidation and lipolysis in adipocytes, but may induce an increase in energy expenditure. trans-10,cis-12 CLA exhibited greater influence on lipid metabolism, stimulated adipocyte energy expenditure, apoptosis and fatty acid oxidation, but its effect on lipolysis was not obvious.</description><dc:title>Different mechanisms of cis-9,trans-11- and trans-10,cis-12- conjugated linoleic acid affecting lipid metabolism in 3T3-L1 cells - Corrected Proof</dc:title><dc:creator>Jia-jie Zhai, Zhao-liang Liu, Jie-mei Li, Jian-Ping Chen, Lin Jiang, Dong-mei Wang, Jin Yuan, Jian-Gang Shen, De-Po Yang, Jia-Qi Chen</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-08</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-08</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002095/abstract?rss=yes"><title>TaqIB polymorphism in the CETP gene modulates the impact of HC/LF diet on the HDL profile in healthy Chinese young adults - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002095/abstract?rss=yes</link><description>Abstract: The aim of this study was to investigate the interactions of genetic variants in the genes of cholesterol ester transfer protein (CETP) and low-density lipoprotein receptor (LDLR) with high carbohydrate and low fat (HC/LF) diet on lipid profiles in a young and healthy Chinese Han population. Fifty-six healthy subjects (22.89±1.80 years) were given washout diets of 31% fat and 54% carbohydrate for 7 days, followed by HC/LF diets of 15% fat and 70% carbohydrate for 6 days, with no total energy restriction. Serum lipid profiles at baseline, after washout and following HC/LF diets, as well as CETP and LDLR polymorphisms were analyzed. Carriers of B2 allele of CETP TaqIB polymorphism had significantly higher levels of high density lipoprotein cholesterol (HDL-C) and apo A-I in the whole study population after the diet intervention. Notably, males with CETP TaqIB B1B1 experienced significantly increased HDL-C and apo A-I after HC/LF diet. Regarding the LDLR Pvu II polymorphism, both P1P1 subjects and P2 carriers experienced decreased total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels after HC/LF diet with no statistically significant differences between the genotypes. Our results demonstrate that the elevated HDL-C levels after HC/LF diet in healthy Chinese Han youth are associated with CETP TaqI B2 allele while males with B1B1 genotype are more susceptible to the influence of HC/LF diet on their HDL-C levels. The decreased TC and LDL-C levels after HC/LF diet are not associated with LDLR Pvu II polymorphism.</description><dc:title>TaqIB polymorphism in the CETP gene modulates the impact of HC/LF diet on the HDL profile in healthy Chinese young adults - Corrected Proof</dc:title><dc:creator>Juan Du, Ding Zhi Fang, Jia Lin, Li Ying Xiao, Xue Dong Zhou, Sarah Shigdar, Wei Duan</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-08</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-08</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002204/abstract?rss=yes"><title>Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002204/abstract?rss=yes</link><description>Abstract: Oxidative stress contributes towards the development of nonalcoholic steatohepatitis (NASH). Thus, antioxidants may decrease oxidative stress and ameliorate the events contributing to NASH. We hypothesized that α- or γ-tocopherol would protect against lipopolysaccharide (LPS)-triggered NASH in an obese (ob/ob) mouse model. Five-week-old obese mice (n=18/dietary treatment) were provided 15 mg/kg each of α- and γ-tocopherol or 500 mg/kg of α- or γ-tocopherol for 5-weeks. Then, all mice were injected ip once with LPS (250 μg/kg) before being sacrificed at 0, 1.5 or 6 h. Body weight and hepatic steatosis were unaffected by tocopherols and LPS. Hepatic α- and γ-tocopherol increased (P&lt;.05) ~9.8- and 10-fold in respective tocopherol supplemented mice and decreased in response to LPS. LPS increased serum alanine aminotransferase (ALT) by 86% at 6 h and each tocopherol decreased this response by 29–31%. By 6 h, LPS increased hepatic malondialdehyde (MDA) and tumor necrosis factor-α by 81% and 44%, respectively, which were decreased by α- or γ-tocopherol. Serum ALT was correlated (P&lt;.05) to hepatic tumor necrosis factor-α (r=0.585) and MDA (r=0.592), suggesting that inflammation and lipid peroxidation contributed to LPS-triggered hepatic injury. α- and γ-Tocopherol similarly attenuated LPS-triggered increases in serum free fatty acid, and α-tocopherol only maintained the LPS-triggered serum triacylglycerol responses at 6 h. These findings indicate that increasing hepatic α- or γ-tocopherol protected against LPS-induced NASH by decreasing liver damage, lipid peroxidation, and inflammation without affecting body mass or hepatic steatosis. Further study is needed to define the mechanisms by which these tocopherols protected against LPS-triggered NASH.</description><dc:title>Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis - Corrected Proof</dc:title><dc:creator>Min-Yu Chung, Steven F. Yeung, Hea Jin Park, Jeff S. Volek, Richard S. Bruno</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-08</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-08</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002034/abstract?rss=yes"><title>Gestational zinc deficiency affects the regulation of transcription factors AP-1, NF-κB and NFAT in fetal brain - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002034/abstract?rss=yes</link><description>Abstract: Transcription factors AP-1, nuclear factor κB (NF-κB) and NFAT are central to brain development by regulating the expression of genes that modulate cell proliferation, differentiation, apoptosis and synaptic plasticity. This work investigated the consequences of feeding zinc-deficient and marginal zinc diets to rat dams during gestation on the modulation of AP-1, NF-κB and NFAT in fetal brain. Sprague–Dawley rats were fed from gestation day (GD) 0 a control diet ad libitum (25 μg zinc/g diet, C), a zinc-deficient diet ad libitum (0.5 μg zinc/g diet, ZD), the control diet in the amounts eaten by the ZD rats (restrict fed, RF) or a diet containing a marginal zinc concentration ad libitum (10 μg zinc/g diet, MZD) until GD 19. AP-1-DNA binding was higher (50–190%) in nuclear fraction isolated from ZD, RF and MZD fetal brains compared to controls. In MZD fetal brain, high levels of activation of the upstream mitogen-activated protein kinases JNK and p38 and low levels of ERK phosphorylation were observed. Total levels of NF-κB and NFAT activation were higher or similar in the ZD and MZD groups than in controls, respectively. However, NF-κB- and NFAT-DNA binding in nuclear fractions was markedly lower in ZD and MZD fetal brain than in controls (50–80%). The latter could be related to zinc deficiency-associated alterations of the cytoskeleton, which is required for NF-κB and NFAT nuclear transport. In summary, suboptimal zinc nutrition during gestation could cause long-term effects on brain function, partially through a deregulation of transcription factors AP-1, NF-κB and NFAT.</description><dc:title>Gestational zinc deficiency affects the regulation of transcription factors AP-1, NF-κB and NFAT in fetal brain - Corrected Proof</dc:title><dc:creator>Lucila Aimo, Gerardo G. Mackenzie, Alison H. Keenan, Patricia I. Oteiza</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-01-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002058/abstract?rss=yes"><title>Age- and brain region-specific effects of dietary vitamin K on myelin sulfatides - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002058/abstract?rss=yes</link><description>Abstract: Dysregulation of myelin sulfatides is a risk factor for cognitive decline with age. Vitamin K is present in high concentrations in the brain and has been implicated in the regulation of sulfatide metabolism. Our objective was to investigate the age-related interrelation between dietary vitamin K and sulfatides in myelin fractions isolated from the brain regions of Fischer 344 male rats fed one of two dietary forms of vitamin K: phylloquinone or its hydrogenated form, 2′,3′-dihydrophylloquinone (dK), for 28 days. Both dietary forms of vitamin K were converted to menaquinone-4 (MK-4) in the brain. The efficiency of dietary dK conversion to MK-4 compared to dietary phylloquinone was lower in the striatum and cortex, and was similar to that in the hippocampus. There were significant positive correlations between sulfatides and MK-4 in the hippocampus (phylloquinone-supplemented diet, 12 and 24 months; dK-supplemented diet, 12 months) and cortex (phylloquinone-supplemented diet, 12 and 24 months). No significant correlations were observed in the striatum. Furthermore, sulfatides in the hippocampus were significantly positively correlated with MK-4 in serum. This is the first attempt to establish and characterize a novel animal model that exploits the inability of dietary dK to convert to brain MK-4 to study the dietary effects of vitamin K on brain sulfatide in brain regions controlling motor and cognitive functions. Our findings suggest that this animal model may be useful for investigation of the effect of the dietary vitamin K on sulfatide metabolism, myelin structure and behavior functions.</description><dc:title>Age- and brain region-specific effects of dietary vitamin K on myelin sulfatides - Corrected Proof</dc:title><dc:creator>Natalia A. Crivello, Sherley L. Casseus, James W. Peterson, Donald E. Smith, Sarah L. Booth</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-01-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002150/abstract?rss=yes"><title>An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002150/abstract?rss=yes</link><description>Abstract: Obesity, the related metabolic syndrome and associated liver diseases represent an epidemic problem and demand for effective therapeutic strategies. In this regard, natural compounds derived from Oriental medicine such as green tea polyphenols influencing adipogenesis attract growing attention. In Korea, an aqueous extract from the Japanese spice bush Lindera obtusiloba is traditionally used for treatment of inflammation and prevention of liver damage. We here investigated effects of the L. obtusiloba extract on cell growth, apoptosis, Wnt signaling and differentiation of (im)mature adipocytes using 3T3-L1, an established cell line for studying adipogenesis. L. obtusiloba extract reduced the de‑novo DNA synthesis of 3T3-L1 preadipocytes in a concentration dependent manner with an IC50 of ∼135 μg/ml paralleled by induction of caspase‑3/7 mediated apoptosis. Hormone-induced 3T3‑L1 differentiation in the presence of L. obtusiloba extract resulted in a reduced accumulation of intracellular lipid droplets by 70%, in down-regulated expression of the adipogenesis-associated proteins glucose transporter-4 and vascular endothelial growth factor, in reduced secretion of the proadipogenic matrix metalloproteinase-2, and in dampened phosphorylation of the Wnt pathway effector protein β-catenin with subsequent diminished expression of the peroxisome proliferator-activated receptor-γ. Treatment of mature adipocytes with L. obtusiloba extract also significantly reduced intracellular lipid droplets. In addition to this strong interference of L. obtusiloba extract with adipogenesis, L. obtusiloba extract exerted anti-inflammatory effects. L. obtusiloba extract significantly attenuated lipopolysaccharide- and tumor necrosis factor α-induced secretion of IL-6 by preadipocytes, thus influencing insulin resistance and inflammatory state characterizing obesity. In conclusion, extracts of L. obtusiloba should be evaluated as a potential complementary treatment option for obesity associated with the metabolic syndrome.</description><dc:title>An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes - Corrected Proof</dc:title><dc:creator>Christian Freise, Ulrike Erben, Ulf Neuman, Kiyoung Kim, Martin Zeitz, Rajan Somasundaram, Martin Ruehl</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.013</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-01-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002162/abstract?rss=yes"><title>Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002162/abstract?rss=yes</link><description>Abstract: Abscisic acid (ABA) is a natural phytohormone which improves insulin sensitivity and reduces adipose tissue inflammation when supplemented into diets of obese mice. The objective of this study was to investigate the mechanisms by which ABA prevents or ameliorates atherosclerosis. apolipoprotein E-deficient (ApoE−/−) mice were fed high-fat diets with or without ABA for 84 days. Systolic blood pressure was assessed on Days 0, 28, 56 and 72. Gene expression, immune cell infiltration and histological lesions were evaluated in the aortic root wall. Human aortic endothelial cells were used to examine the effect of ABA on 3′,5′-cyclic adenosine monophosphate (cAMP) and nitric oxide (NO) production in vitro. We report that ABA-treated mice had significantly improved systolic blood pressure and decreased accumulation of F4/80+CD11b+ macrophages and CD4+ T cells in aortic root walls. At the molecular level, ABA significantly enhanced aortic endothelial nitric oxide synthase (eNOS) and tended to suppress aortic vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) expression and plasma MCP-1 concentrations. ABA also caused a dose-dependent increase in intracellular concentrations of cAMP and NO and up-regulated eNOS mRNA expression in human aortic endothelial cells. This is the first report showing that ABA prevents or ameliorates atherosclerosis-induced hypertension, immune cell recruitment into the aortic root wall and up-regulates aortic eNOS expression in ApoE−/− mice.</description><dc:title>Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall - Corrected Proof</dc:title><dc:creator>Amir J. Guri, Sarah A. Misyak, Raquel Hontecillas, Alyssa Hasty, Dongmin Liu, Hongwei Si, Josep Bassaganya-Riera</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-01-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002216/abstract?rss=yes"><title>Hypocholesterolemic activity of grape seed proanthocyanidin is mediated by enhancement of bile acid excretion and up-regulation of CYP7A1 - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002216/abstract?rss=yes</link><description>Abstract: Interest in grape seed proanthocyanidin (GSP) as a cholesterol-lowering nutraceutical is growing. This study was to investigate the effect of GSP on blood cholesterol level and gene expression of cholesterol-regulating enzymes in Golden Syrian hamsters maintained on a 0.1% cholesterol diet. Results affirmed supplementation of 0.5% or 1.0% GSP could decrease plasma total cholesterol and triacylglycerol level. Western blot and real-time polymerase chain reaction analyses demonstrated GSP did not affect sterol regulatory element binding protein-2 and low-density lipoprotein receptor; however, it increased mRNA 3-hydroxy-3-methylglutaryl coenzyme A reductase. GSP had no effect on the protein mass of liver X receptor alpha (LXRα) but it decreased mRNA LXRα. Most importantly, GSP increased not only the protein level of cholesterol-7α-hydroxylase (CYP7A1) but also mRNA CYP7A1. It was concluded that the hypocholesterolemic activity of GSP was most likely mediated by enhancement of bile acid excretion and up-regulation of CYP7A1.</description><dc:title>Hypocholesterolemic activity of grape seed proanthocyanidin is mediated by enhancement of bile acid excretion and up-regulation of CYP7A1 - Corrected Proof</dc:title><dc:creator>Rui Jiao, Zesheng Zhang, Hongjian Yu, Yu Huang, Zhen-Yu Chen</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-01-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528630900223X/abstract?rss=yes"><title>Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528630900223X/abstract?rss=yes</link><description>Abstract: Sesamol is a potent phenolic antioxidant which possesses antimutagenic, antihepatotoxic and antiaging properties. Platelet activation is relevant to a variety of acute thrombotic events and coronary heart diseases. There have been few studies on the effect of sesamol on platelets. Therefore, the aim of this study was to systematically examine the detailed mechanisms of sesamol in preventing platelet activation in vitro and in vivo. Sesamol (2.5−5 μM) exhibited more potent activity of inhibiting platelet aggregation stimulated by collagen than other agonists. Sesamol inhibited collagen-stimulated platelet activation accompanied by [Ca2+]i mobilization, thromboxane A2 (TxA2) formation, and phospholipase C (PLC)γ2, protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) phosphorylation in washed platelets. Sesamol markedly increased cAMP and cGMP levels, endothelial nitric oxide synthase (eNOS) expression and NO release, as well as vasodilator-stimulated phosphoprotein (VASP) phosphorylation. SQ22536, an inhibitor of adenylate cyclase, markedly reversed the sesamol-mediated inhibitory effects on platelet aggregation and p38 MAPK phosphorylation, and sesamol-mediated stimulatory effects on VASP and eNOS phosphorylation, and NO release. Sesamol also reduced hydroxyl radical (OH●) formation in platelets. In an in vivo study, sesamol (5 mg/kg) significantly prolonged platelet plug formation in mice. The most important findings of this study demonstrate for the first time that sesamol possesses potent antiplatelet activity, which may involve activation of the cAMP-eNOS/NO-cGMP pathway, resulting in inhibition of the PLCγ2-PKC-p38 MAPK-TxA2 cascade, and, finally, inhibition of platelet aggregation. Sesamol treatment may represent a novel approach to lowering the risk of or improving function in thromboembolism-related disorders.</description><dc:title>Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase - Corrected Proof</dc:title><dc:creator>Chao C. Chang, Wan J. Lu, Cheng W. Chiang, Thanasekaran Jayakumar, Eng T. Ong, George Hsiao, Tsorng H. Fong, Duen S. Chou, Joen R. Sheu</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-16</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-16</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001910/abstract?rss=yes"><title>Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001910/abstract?rss=yes</link><description>Abstract: Echinacea preparations were the top-selling herbal supplements or medicines in the past decade; however, there is still frequent misidentification or substitution of the Echinacea plant species in the commercial Echinacea products with not well chemically defined compositions in a specific preparation. In this report, a comparative metabolomics study, integrating supercritical fluid extraction, gas chromatography/mass spectrometry and data mining, demonstrates that the three most used medicinal Echinacea species, Echinacea purpurea, E. pallida, and E. angustifolia, can be easily classified by the distribution and relative content of metabolites. A mitogen-induced murine skin inflammation study suggested that alkamides were the active anti-inflammatory components present in Echinacea plants. Mixed alkamides and the major component, dodeca-2E,4E,8Z,10Z(E)-tetraenoic acid isobutylamides (8/9), were then isolated from E. purpurea root extracts for further bioactivity elucidation. In macrophages, the alkamides significantly inhibited cyclooxygenase 2 (COX-2) activity and the lipopolysaccharide-induced expression of COX-2, inducible nitric oxide synthase and specific cytokines or chemokines [i.e., TNF-α, interleukin (IL)-1α, IL-6, MCP-1, MIP-1β] but elevated heme oxygenase-1 protein expression. Cichoric acid, however, exhibited little or no effect. The results of high-performance liquid chromatography/electron spray ionization/mass spectrometry metabolite profiling of alkamides and phenolic compounds in E. purpurea roots showed that specific phytocompound (i.e., alkamides, cichoric acid and rutin) contents were subject to change under certain post-harvest or abiotic treatment. This study provides new insight in using the emerging metabolomics approach coupled with bioactivity assays for medicinal/nutritional plant species classification, quality control and the identification of novel botanical agents for inflammatory disorders.</description><dc:title>Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants - Corrected Proof</dc:title><dc:creator>Chia-Chung Hou, Chun-Houh Chen, Ning-Sun Yang, Yi-Ping Chen, Chiu-Ping Lo, Sheng-Yang Wang, Yin-Jing Tien, Pi-Wen Tsai, Lie-Fen Shyur</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-11</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-11</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528630900165X/abstract?rss=yes"><title>Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean-style diet in high-cardiovascular-risk subjects - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528630900165X/abstract?rss=yes</link><description>Abstract: The first results of the PREDIMED (PREvencion con Dieta MEDiterranea) randomized trial, after 3-month intervention, showed that the Mediterranean Diet (MD), supplemented with either virgin olive oil (VOO) or nuts, reduced systolic blood pressure, serum cholesterol and triacylglycerol (TG) concentrations and increased high-density lipoprotein (HDL)-cholesterol when compared to a control (low-fat diet) group. Serum TG levels are an independent risk factor for coronary heart disease and are strongly determined by very low-density lipoprotein (VLDL) composition, which can be specifically modified by dietary lipid source. Within the context of the PREDIMED study, we assessed the VLDL composition in 50 participants after 3 months of intake of two MD, supplemented with VOO or nuts, compared with a low-fat diet. Total and low-density lipoprotein cholesterol concentrations were reduced in subjects on the MD+nuts, whereas HDL-cholesterol increased after consumption of the MD+VOO. Serum TG concentrations were significantly lowered in both intervention groups (either the MD+nuts or MD+VOO). However, only the MD+VOO reduced the VLDL-cholesterol and VLDL-TG content and the TG/apolipoprotein B ratio in VLDL, which was used to estimate particle size. Although VLDL-TG fatty acids were very slightly modified, VLDL-TG molecular species in VLDL after consumption of the MD+nuts were characterized by a higher presence of linoleic acid (18:2, n-6), whereas after the intake of MD+VOO, they were rich in oleic acid (18:1, n-9). Therefore, we conclude that the reduction in systemic TG concentrations observed after consumption of the MD may be explained by reduction of the lipid core of VLDL and a selective modification of the molecular species composition in the particle.</description><dc:title>Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean-style diet in high-cardiovascular-risk subjects - Corrected Proof</dc:title><dc:creator>Javier S. Perona, María-Isabel Covas, Montserrat Fitó, Rosana Cabello-Moruno, Fernando Aros, Dolores Corella, Emilio Ros, Maria Garcia, Ramon Estruch, Miguel A. Martinez-Gonzalez, Valentina Ruiz-Gutierrez</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001727/abstract?rss=yes"><title>Effects of a grapeseed procyanidin extract (GSPE) on insulin resistance - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001727/abstract?rss=yes</link><description>Abstract: Flavonoids are beneficial compounds against risk factors for metabolic syndrome, but their effects and the mechanisms on glucose homeostasis modulation are not well defined. In the present study, we first checked the efficacy of grapeseed procyanidin extract (GSPE) for stimulating glucose uptake in insulin-resistant 3T3-L1 adipocytes. Results show that when resistance is induced with chronic insulin treatment, GSPE maintain a higher stimulating capacity than insulin. In contrast, when dexamethasone is used as the resistance-inducing agent, GSPE is less effective. Next we evaluated how effective different GSPE treatments are at improving glucose metabolism in hyperinsulinemic animals (fed a cafeteria diet). GSPE reduced plasma insulin levels. The lower dose (25 mg GSPE/kg body weight per day) administered for 30 days improved the HOmeostasis Model Assessment-insulin resistance index. This was accompanied by down-regulation of Pparg2, Glut4 and Irs1 in mesenteric white adipose tissue. Similarly, a chronic GSPE treatment of insulin-resistant 3T3-L1 adipocytes down-regulated the mRNA levels of those adipocyte markers, although cells were still able to respond to the acute stimulation of glucose uptake.In summary, 25 mg/kg body weight per day of GSPE has a positive long-term effect on glucose homeostasis, and GSPE could be targeted at adipose tissue, where it might directly stimulate glucose uptake. This work also highlights the need to carefully consider the bioactive dose, since a higher dose does not necessarily correlate to a greater positive effect.</description><dc:title>Effects of a grapeseed procyanidin extract (GSPE) on insulin resistance - Corrected Proof</dc:title><dc:creator>Gemma Montagut, Cinta Bladé, Mayte Blay, Juan Fernández-Larrea, Gerard Pujadas, M. Josepa Salvadó, Lluís Arola, Montserrat Pinent, Anna Ardévol</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001739/abstract?rss=yes"><title>Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001739/abstract?rss=yes</link><description>Abstract: The purpose of this study was to explore the bioavailability, efficacy and molecular mechanisms of green tea polyphenols (GTP) related to preventing bone loss in rats with chronic inflammation. A 2 [placebo vs. lipopolysaccharide (LPS)]×2 (no GTP vs. 0.5% GTP in drinking water) factorial design enabled the evaluation of effects of LPS administration, GTP levels, and LPS×GTP interaction. Urinary GTP components and 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels were determined by high-pressure liquid chromatography for bioavailability and molecular mechanism, respectively. Efficacy was evaluated by examining changes in femoral mineral content (BMC) and density (BMD) using dual-energy X-ray absorptiometry, and bone turnover biomarkers [osteocalcin (OC) and tartrate-resistant acid phosphatase (TRAP)] using respective ELISA kits. The mRNA expression of tumor necrosis factor-α (TNF-α) and cyclooxygenase-2 (COX-2) in spleen was determined by real-time RT-PCR. Neither LPS administration nor GTP levels affected body weight and femoral bone area throughout the study period. Only GTP supplementation resulted in increased urinary epigallocatechin and epicatechin concentrations. LPS administration led to a decrease in femur BMC and BMD, and serum OC levels, but an increase in serum TRAP, urinary 8-OHdG and spleen mRNA expression of TNF-α and COX-2 levels. GTP supplementation resulted in higher values for femur BMC, BMD and serum OC, but lower values for serum TRAP, urinary 8-OHdG and spleen mRNA expression of TNF-α and COX-2 levels. We conclude that GTP mitigates bone loss in a chronic inflammation-induced bone loss model by reducing oxidative stress-induced damage and inflammation.</description><dc:title>Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model - Corrected Proof</dc:title><dc:creator>Chwan-Li Shen, James K. Yeh, Jay J. Cao, Owatha L. Tatum, Raul Y. Dagda, Jia-Sheng Wang</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001806/abstract?rss=yes"><title>Association of MT1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001806/abstract?rss=yes</link><description>Abstract: Metallothioneins (MT), the antioxidant zinc-binding proteins, seem to mediate cardioprotection. It has been postulated that zinc homeostasis and MT function may be altered, as a consequence of oxidative stress, in cardiovascular disease (CVD), with a potential implication of MT genetic polymorphisms. The present study explores the role of +647A/C and +1245A/G MT1A polymorphisms on the susceptibility to CVD, zinc status and enzyme antioxidant activity, in the Greek and Italian populations. The country selection was based on the lower zinc status and the reduced zinc dietary intake in Greece than in Italy despite the similar Mediterranean dietary pattern. A total of 464 old, healthy control subjects and 369 old CVD patients more than 70 years of age were studied. Logistic regression model indicated that +1245 MT1A G+ genotype significantly increased the risk of CVD in Greece (34.4% vs. 23.2%; odds ratio=1.88, 95% confidence interval=1.14–3.08; P=.013) but not in Italy. Haplotype analysis showed an increment of CG haplotype frequency in CVD Greek patients (17.4% vs. 10.6%, P&lt;.05). Differential country-related frequency distribution was also recorded. Applying a multivariate regression model, +647/+1245 MT1A haplotype was associated with a modulation of enzyme antioxidant activities in both countries. Decreased plasma zinc and reduced intracellular Zn release, as well as increased enzyme antioxidant activity, were more apparent in Greek healthy donors than in Italy. In conclusion, +1245 MT1A polymorphism and +647/+1245 MT1A haplotype are implicated in CVD in Greece but not in Italy, suggesting a role of gene–diet interaction in the disease predisposition.</description><dc:title>Association of MT1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort - Corrected Proof</dc:title><dc:creator>Robertina Giacconi, Stavroula Kanoni, Patrizia Mecocci, Marco Malavolta, Dimitris Richter, Sara Pierpaoli, Laura Costarelli, Catia Cipriano, Elisa Muti, Francesca Mangialasche, Francesco Piacenza, Silvia Tesei, Roberta Galeazzi, Eirini V. Theodoraki, Fabrizia Lattanzio, George Dedoussis, Eugenio Mocchegiani</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001909/abstract?rss=yes"><title>Green tea polyphenol (−)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001909/abstract?rss=yes</link><description>Abstract: Green tea polyphenol (−)-epigallocatechin gallate (EGCG) has been reported to reduce neuronal damage after cerebral ischemic insult. EGCG is known to reduce matrix metalloproteinase (MMP) activity. MMP can play an important role in the pathophysiology of neurological disorders including cerebral ischemia. The purpose of the current study was to investigate whether EGCG shows an inhibitory effect on MMP activity and neural tissue damage following transient focal cerebral ischemia. In the present study, C57BL/6 mice were subjected to 80 min of focal ischemia induced by middle cerebral artery occlusion (MCAO). Animals were killed 24 h after ischemia. EGCG (50 mg/kg) was administered intraperitoneally immediately after ischemia. Gelatin gel zymography showed an increase in the active form of MMP-9 after ischemia. EGCG reduced ischemia-induced up-regulation of the active form of MMP-9. In in situ zymography, EGCG reduced up-regulation of gelatinase activity induced by cerebral ischemia. Co-incubation with EGCG reduced gelatinase activity directly in postischemic brain section. In 2,3,5-triphenyltetrazolium chloride (TTC) assay, brain infarction was remarkable in the middle cerebral artery territory after focal cerebral ischemia. In EGCG-treated mice, infarct volume was significantly reduced compared with vehicle-treated mice. These results demonstrate that EGCG, a green tea polyphenol, may reduce up-regulation of MMP-9 activity and neuronal damage following transient focal cerebral ischemia. In addition to its antioxidant effect, MMP-9 inhibition might be a possible mechanism potentially involved in the neuroprotective effect of a green tea polyphenol, EGCG.</description><dc:title>Green tea polyphenol (−)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia - Corrected Proof</dc:title><dc:creator>Jong-Wook Park, Jung-Seok Hong, Kyoung-Suk Lee, Hahn-Young Kim, Jung-Jeung Lee, Seong-Ryong Lee</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002083/abstract?rss=yes"><title>Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002083/abstract?rss=yes</link><description>Abstract: We hypothesized that consumption of soy protein isolate (SPI) or the soy isoflavone genistein (GEN) would modulate mRNA expression of genes underlying lipid and thyroid hormone metabolism in livers and small intestines of young adult male Sprague–Dawley rats. Early pregnant rat dams were placed on AIN-93G diets containing casein (CAS, control protein), SPI, or CAS+GEN. Litters were weaned to the same diet as their dam. SPI-fed (but not GEN-fed) male rats of 48 days of age had significant reductions in body weight, abdominal fat pad weight and hepatic content of lipid droplets and triglycerides. Hepatic peroxisome proliferator-activated receptor α (Ppara) transcripts were elevated with SPI but not GEN diet. Hepatic pyruvate dehydrogenase kinase-4 (Pdk4) and cytochrome P450 4A10 (Cyp4a10) mRNA abundance was reduced with SPI; the SPI effect on Cyp4a10 was recapitulated by GEN diet. SPI (but not GEN) suppressed Pdk4 and 3-hydroxy-3-methylglutaryl-CoA synthase 2 (Hmgcs2) mRNA abundance in duodenum. Liver iodothyronine deiodinase types 1 and 2 (Dio1 and Dio2) mRNA levels were increased with SPI diet; the effect on Dio2, but not Dio1 mRNAs, also was observed with GEN. SPI and GEN increased hepatic types 1 and 2 iodothyronine deiodinase (D1 and D2) activities. Effects of SPI and GEN on the above gene expression may contribute to the observed reductions in body and adipose tissue weight and liver lipid content in this model. Identification of the regulation, by genistein and soy protein, of iodothyronine deiodinase synthesis has potential applications for treatment and prevention of fatty liver disease and obesity.</description><dc:title>Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat - Corrected Proof</dc:title><dc:creator>Frank A. Simmen, Charles P. Mercado, Ann Marie Zavacki, Stephen A. Huang, Amy D. Greenway, Ping Kang, Margaret T. Bowman, Ronald L. Prior</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-04</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-04</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001326/abstract?rss=yes"><title>Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001326/abstract?rss=yes</link><description>Abstract: Backgound: Animal studies suggest that reactive oxygen species (ROS) play an important role in the development of diabetic cardiomyopathy.Hypothesis: Matrix metalloproteinase-2 (MMP-2) is activated by ROS and contributes to the acute loss of myocardial contractile function by targeting and cleaving susceptible proteins including troponin I (TnI) and α-actinin.Methods: Using the streptozotocin-induced diabetic rat model, we evaluated the effect of daily in vivo administration of sodium selenate (0.3 mg/kg; DMS group), or a pure omega-3 fish oil with antioxidant vitamin E (omega-3E; 50 mg/kg; DMFA group), which has antioxidant-like effects, for 4 weeks on heart function and on several biochemical parameters related to oxidant stress and MMP-2.Results: Although both treatments prevented the diabetes-induced depression in left ventricular developed pressure (LVDP) as well as the rates of changes in developed pressure (±dP/dt) (P&lt;.001), the improvement in LVDP of the DMS group was greater compared to that of the DMFA group (P&lt;.001). Moreover, these treatments reduced the diabetes-induced increase in myocardial oxidized protein sulfhydryl and nitrite concentrations (P&lt;.001). Gelatin zymography and Western blot data indicated that the diabetes-induced changes in myocardial levels of MMP-2 and tissue inhibitor of matrix metalloproteinase-4 (TIMP-4) and the reduction in TnI and α-actinin protein levels were improved in both the DMS and DMFA groups (P&lt;.001).Conclusions: These results suggest that diabetes-induced alterations in MMP-2 and TIMP-4 contribute to myocardial contractile dysfunction by targeting TnI and α-actinin and that sodium selenate or omega-3E could have therapeutic benefits in diabetic cardiomyopathy.</description><dc:title>Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress - Corrected Proof</dc:title><dc:creator>Aslihan Aydemir-Koksoy, Ayca Bilginoglu, Meltem Sariahmetoglu, Richard Schulz, Belma Turan</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001636/abstract?rss=yes"><title>Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7S globulin α′ subunit involved in Hep G2 cell cholesterol homeostasis - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001636/abstract?rss=yes</link><description>Abstract: A truncated form of α′ chain (tα′), the soybean 7S globulin subunit previously demonstrated to be active in controlling the cholesterol and triglyceride homeostasis in in vitro and in vivo models, was cloned and expressed in the yeast Pichia pastoris. The recombinant polypeptide spanned 216 amino acid residues from the N-terminal side and included the N-terminal extension region of the soybean subunit. The tα′ polypeptide was purified by conventional biochemical techniques, and its potential to modulate the activity of low-density lipoprotein (LDL) receptor was evaluated in a human hepatoma cell line (Hep G2) by monitoring the uptake and degradation of labeled LDL. The LDL uptake (+192%) and degradation (+143%) by cells tested at the highest tα′ dose (8 μM) were similar to those found in cells incubated with 1 μM simvastatin, a potent inhibitor of cholesterol biosynthesis. The cell response to tα′ was found to be dose dependent. The use of a recombinant polypeptide ruled out the involvement of any other soybean component.These findings open new prospects in the studies aimed at identifying soybean regulatory (poly)peptide(s) and the mechanism involved in this biological response, as a gateway to their utilization for the management of human health.</description><dc:title>Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7S globulin α′ subunit involved in Hep G2 cell cholesterol homeostasis - Corrected Proof</dc:title><dc:creator>Alessandro Consonni, Maria Rosa Lovati, Cristina Manzoni, Anna Pizzagalli, Paolo Morazzoni, Marcello Duranti</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001648/abstract?rss=yes"><title>A moderate threonine deficiency affects gene expression profile, paracellular permeability and glucose absorption capacity in the ileum of piglets - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001648/abstract?rss=yes</link><description>Abstract: High dietary threonine extraction by the digestive tract suggests that threonine contributes to maintain gut physiology. In the present study, we evaluated the impact of a low (6.5 g of threonine/kg diet; LT group) or a control well-balanced threonine diet (9.3 g of threonine/kg diet; C group) given to piglets for 2 weeks on ileal permeability and Na+-dependant glucose absorption capacity in Ussing chambers. The paracellular permeability was significantly increased in the ileum of LT compared to C piglets (P=.017). The Na+-dependent glucose absorption capacity showed a nonsignificant increase in the LT piglets. In addition, we analysed ileal gene expression profiles in the LT and C groups using porcine multitissue cDNA microarrays. Compared to the C piglets, the expression of 324 genes was significantly modified in the ileum of the LT piglets: 214 genes were overexpressed (145 annotated) and 110 were down-expressed (79 annotated). Among them, some are involved in immune and defense responses, energy metabolism and protein synthesis. Furthermore, microarray analysis highlights changes in the expression of the gene encoding for the sodium/glucose cotransporter (SGLT1) and of genes involved in the regulation of paracellular permeability (ZO-1, cingulin and myosin light chain kinase). In conclusion, our results indicate that a moderate threonine deficiency affects intestinal functionality.</description><dc:title>A moderate threonine deficiency affects gene expression profile, paracellular permeability and glucose absorption capacity in the ileum of piglets - Corrected Proof</dc:title><dc:creator>Alice Hamard, David Mazurais, Gaëlle Boudry, Isabelle Le Huërou-Luron, Bernard Sève, Nathalie Le Floc'h</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001661/abstract?rss=yes"><title>Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001661/abstract?rss=yes</link><description>Abstract: Oleoylethanolamide (OEA) has been previously reported to regulate food intake and body weight gain when administered intraperitoneally. Nevertheless, little information is available with regard to oral administration. To assess whether oral OEA can also exert a similar effect on body fat, we fed C3H mice a high-fat diet supplemented with either 10 or 100 mg/kg body weight OEA for 4 weeks. OEA supplementation significantly lowered food intake over the 4 weeks and decreased adipose tissue mass. Plasma triglyceride levels were also significantly decreased by OEA treatment. In order to identify the potential molecular targets of OEA action, we screened the expression levels of 44 genes related to body fat mass and food intake in peripheral tissues. Adipose tissue fatty acid amide hydrolase (FAAH), intestinal fatty acid transporter/cluster of differentiation 36 and the OEA receptor G-protein-coupled receptor 119 (GPR119) were among the most OEA-responsive genes. They were also associated with reduced body fat pads regardless of the dose. Adipose FAAH was found to be primarily associated with a decrease in food intake. Our data suggest that the anti-obesity activity of OEA partially relies on modulation of the FAAH pathway in adipose tissue. Another mechanism might involve modulation of the newly discovered GPR119 OEA signaling pathway in the proximal intestine. In conclusion, our study indicates that oral administration of OEA can effectively decrease obesity in the mouse model and that modulation of the endocannabinoid fatty acid ethanolamide pathway seems to play an important role both in adipose tissue and in small intestine.</description><dc:title>Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice - Corrected Proof</dc:title><dc:creator>Clémentine Thabuis, Frédéric Destaillats, Jean-François Landrier, Delphine Tissot-Favre, Jean-Charles Martin</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001673/abstract?rss=yes"><title>Dietary fish oil inhibits the early stage of recovery of atrophied soleus muscle in rats via Akt–p70s6k signaling and PGF2α - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001673/abstract?rss=yes</link><description>Abstract: Skeletal muscle recovery from disuse atrophy requires the recruitment of insulin signaling for muscle growth, which is driven by protein synthesis. Dietary fish oil, which is rich in long-chain n−3 polyunsaturated fatty acids, is known to enhance insulin signaling and protein metabolism. Therefore, this study was performed to evaluate whether dietary fish oil facilitates muscle recovery during remobilization after disuse atrophy. Ten days of immobilization, followed by 3 or 13 days of remobilization, were applied to the hindlimbs of rats fed corn oil [corn oil diet group as control (CO)] or fish oil [fish oil diet group (FO)] as source of dietary fat. The immobilization-induced reductions in soleus muscle weight and myosin heavy-chain content were significantly restored by 3 days of remobilization in CO. However, in FO, these muscle recovery measurements did not significantly change until 13 days of remobilization. At 3 days of remobilization, both groups had significant elevations in p70 ribosomal S6 kinase (p70s6k) activation and at a greater extent in CO than in FO. The activation of Akt was also increased on Day 3, but it was not significant in FO. Throughout the remobilization period, levels of prostaglandin F2α (PGF2α) and cyclooxygenase-2 mRNA were significantly augmented. However, FO had a lesser increase in PGF2α than CO until Day 13. These findings indicate that dietary fish oil inhibits the early stage of soleus muscle recovery after disuse atrophy by suppressing the activation of Akt–p70s6k signaling and PGF2α synthesis.</description><dc:title>Dietary fish oil inhibits the early stage of recovery of atrophied soleus muscle in rats via Akt–p70s6k signaling and PGF2α - Corrected Proof</dc:title><dc:creator>Jae-Sung You, Mi-Na Park, Yeon-Sook Lee</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001697/abstract?rss=yes"><title>Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001697/abstract?rss=yes</link><description>Abstract: Obesity and insulin resistance have been linked to a low-grade chronic inflammatory response characterized by increased macrophage infiltration, altered cytokine production and activation of inflammatory signaling pathway in adipose tissue. Pharmacological agents and natural products that are capable of reducing inflammatory activity possess anti-diabetic properties. Luteolin, a naturally occurring flavonoid, has been demonstrated to inhibit lipopolysaccharide-induced tumor necrosis factor-α (TNFα) release and activation of NF-κB pathway in macrophages. However, little is known about the mechanism and effect of luteolin on inflammation-related insulin resistance in adipocytes. In this study, we investigated the effect of luteolin on insulin action in 3T3-L1 adipocytes and primary adipose cells. Here we showed that luteolin treatment for 24 h increased the response of glucose uptake to insulin stimulation in 3T3-L1 adipocytes. Our results also demonstrated that luteolin enhanced Akt2 phosphorylation in an insulin-stimulated state. Furthermore, luteolin treatment decreased mRNA levels of TNFα, interleukin-6 and MCP-1, while it increased the gene expression of adiponectin and leptin in 3T3-L1 adipocytes and primary mouse adipose cells. Most interestingly, we found that treatment of luteolin markedly enhanced peroxisome proliferator-activated receptor γ (PPARγ) transcriptional activity in 3T3-L1 adipocytes, and luteolin-increased expression of adiponectin and leptin was blocked by GW9662, a PPARγ antagonist. Thus, our data suggest that luteolin influences insulin action and production of adipokines/cytokines in adipocytes by activating the PPARγ pathway.</description><dc:title>Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes - Corrected Proof</dc:title><dc:creator>Li Ding, Daozhong Jin, Xiaoli Chen</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001703/abstract?rss=yes"><title>Reduction in cardiovascular risk by sodium-bicarbonated mineral water in moderately hypercholesterolemic young adults - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001703/abstract?rss=yes</link><description>Abstract: The effects of drinking sodium-bicarbonated mineral water on cardiovascular risk in young men and women with moderate cardiovascular risk were studied. Eighteen young volunteers (total cholesterol levels &gt;5.2 mmol/L) without any disease participated. The study consisted of two 8-week intervention periods. Subjects consumed, as supplement to their usual diet, 1 L/day control low mineral water, followed by 1 L/day bicarbonated mineral water (48 mmol/L sodium, 35 mmol/L bicarbonate and 17 mmol/L chloride). Determinations were performed at the end of the control water period and on Weeks 4 and 8 of the bicarbonated water period. Body weight, body mass index (BMI), blood pressure, dietary intake, total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, apolipoprotein (Apo) A-I, Apo B, triacylgycerols, glucose, insulin, adiponectin, high-sensitivity C-reactive protein (hs-CRP), soluble adhesion molecules [soluble intercellular adhesion molecule (sICAM) and soluble vascular adhesion molecule (sVCAM)], sodium and chloride urinary excretion, and urine pH were measured. Dietary intake, body weight and BMI showed no significant variations. Systolic blood pressure decreased significantly after 4 weeks of bicarbonated water consumption, without significant differences between Weeks 4 and 8. After bicarbonated water consumption, significant reductions in total cholesterol (by 6.3%; P=.012), LDL cholesterol (by 10%; P=.001), total/HDL cholesterol (P=.004), LDL/HDL cholesterol (P=.001) and Apo B (P=.017) were observed. Serum triacylglycerol, Apo A-I, sICAM-1, sVCAM-1 and hs-CRP levels did not change. Serum glucose values tended to decrease during the bicarbonated water intervention (P=.056), but insulin levels did not vary. This sodium-bicarbonated mineral water improves lipid profile in moderately hypercholesterolemic young men and women and could therefore be applied in dietary interventions to reduce cardiovascular risk.</description><dc:title>Reduction in cardiovascular risk by sodium-bicarbonated mineral water in moderately hypercholesterolemic young adults - Corrected Proof</dc:title><dc:creator>Ana M. Pérez-Granados, Santiago Navas-Carretero, Stefanie Schoppen, M. Pilar Vaquero</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001715/abstract?rss=yes"><title>Dietary fish oil n-3 polyunsaturated fatty acids and alpha-linolenic acid differently affect brain accretion of docosahexaenoic acid and expression of desaturases and sterol regulatory element-binding protein 1 in mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001715/abstract?rss=yes</link><description>Abstract: Whether preformed dietary docosahexaenoic acid (DHA) is required for brain accretion has not been clearly determined. In this study, we investigated in mice the different effects of dietary longer-chain n-3 polyunsaturated fatty acids (PUFAs) and α-linolenic acid (LNA) on brain accretion of DHA and the expression of associated desaturases and transcription factors. C57 BL/6J mice were fed for 3 months with four fish oil n-3 PUFA diets — lower, low, high and higher (0.46%, 0.91%, 1.73% and 4.29% total energy, respectively); a flaxseed oil n-3 PUFA (5.01% total energy) diet; and an n-3 PUFA-deficient diet, respectively. Either fish oil or flaxseed oil n-3 PUFA diets increased DHA concentrations in the brain. However, the flaxseed oil n-3 PUFA diet was less effective than the fish oil diet with higher amount of n-3 PUFA in increasing brain DHA content. Furthermore, the expressions of delta-6 desaturase (D6D) and sterol regulatory element binding protein 1 (SREBP-1) in the liver were down-regulated by all fish oil diets with different amounts of n-3 PUFAs, as well as by the flaxseed oil n-3 PUFA diet, whereas in the brain, D6D, delta-5 desaturase (D5D) and SREBP-1 expressions were down-regulated by the higher fish oil n-3 PUFA diet rather than by other fish oil n-3 PUFA and the flaxseed oil n-3 PUFA diets. These results suggest that preformed dietary DHA, different from those converted by LNA inside the body, is better for brain accretion. Dietary longer-chain n-3 PUFAs affect expressions of D6D, D5D and SREBP-1 in the brain differently from their precursor LNA.</description><dc:title>Dietary fish oil n-3 polyunsaturated fatty acids and alpha-linolenic acid differently affect brain accretion of docosahexaenoic acid and expression of desaturases and sterol regulatory element-binding protein 1 in mice - Corrected Proof</dc:title><dc:creator>Haiyan Zhu, Chaonan Fan, Feng Xu, Chunyu Tian, Feng Zhang, Kemin Qi</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001740/abstract?rss=yes"><title>Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001740/abstract?rss=yes</link><description>Abstract: Lecithin:retinol acyltransferase (LRAT) regulates retinol (vitamin A) metabolism by esterifying retinol. LRAT expression is decreased in cultured human squamous cell carcinoma cells of the head and neck relative to normal epithelial cells. We investigated whether the carcinogen 4-nitroquinoline 1-oxide (4-NQO) induced a higher incidence of oral cancer in LRAT knockout (LRAT−/−) than in wild-type (Wt) mice. We also investigated retinol deprivation during 4-NQO treatment in LRAT−/− mice as a model for rapid retinol deficiency. We observed higher levels of secreted frizzled-related protein (Sfrp) 2, an inhibitor of WNT signaling, in tongue tumors in LRAT−/− versus Wt. LRAT−/− embryonic stem cells also expressed higher Sfrp2 transcripts, indicating an interaction between retinol and WNT signaling. Cox-2, Cyclin D1, p21, Trop2 and RARβ2 were not differentially expressed in Wt versus LRAT−/− tongue tumors. Wt and LRAT−/− mice fed a retinol-sufficient diet showed the same oral tumor incidence after 4-NQO treatment. In contrast, tongue tumors developed in 60% of Wt mice and in 100% of LRAT−/− mice fed a retinol-deficient diet during 4-NQO treatment (P=.22); moreover, the bromodeoxyuridine labeling index was 21.0±2.4% in LRAT−/− normal tongue epithelium as compared to 9.9±0.8% in Wt normal tongue epithelium (P&lt;.001). Thus, partial retinol deficiency during carcinogen treatment (achieved in LRAT−/−) resulted in more proliferating cells in tongue epithelia from LRAT−/− mice and, ultimately, a greater probability of carcinogenesis.</description><dc:title>Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice - Corrected Proof</dc:title><dc:creator>Limin Liu, Xiao-Han Tang, Theresa Scognamiglio, Lorraine J. Gudas</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.012</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001752/abstract?rss=yes"><title>Antiobesity mechanisms of action of conjugated linoleic acid - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001752/abstract?rss=yes</link><description>Abstract: Conjugated linoleic acid (CLA), a family of fatty acids found in beef, dairy foods and dietary supplements, reduces adiposity in several animal models of obesity and some human studies. However, the isomer-specific antiobesity mechanisms of action of CLA are unclear, and its use in humans is controversial. This review will summarize in vivo and in vitro findings from the literature regarding potential mechanisms by which CLA reduces adiposity, including its impact on (a) energy metabolism, (b) adipogenesis, (c) inflammation, (d) lipid metabolism and (e) apoptosis.</description><dc:title>Antiobesity mechanisms of action of conjugated linoleic acid - Corrected Proof</dc:title><dc:creator>Arion Kennedy, Kristina Martinez, Soren Schmidt, Susanne Mandrup, Kathleen LaPoint, Michael McIntosh</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001764/abstract?rss=yes"><title>Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001764/abstract?rss=yes</link><description>Abstract: Fasting and postprandial triacylglycerol (TAG) concentrations are risk factors for cardiovascular disease. This study evaluated whether interleukin-6 (IL-6) and incretin hormones [gastric inhibitory peptide (GIP) and glucagon-like peptide-1 (GLP-1) (active)] were associated with fasting and postprandial TAG in response to an oral lipid load, including very-low-density lipoprotein (VLDL) and chylomicron (CM) TAG, following one bout of exercise in nine men (age, 59±2 years; body mass index, 34±2 kg/m2; waist circumference, 113±3 cm) with high fasting TAG (2.9±0.2 mmol/L). Subjects completed two oral fat tolerance tests (OFTTs), randomized 1 week apart, that consisted of 1g fat/kg body weight emulsified lipids in the absence of carbohydrate and protein. Approximately 16 h prior to one OFTT, subjects completed 60 min of treadmill walking (estimated 55% VO2 peak; heart rate, 122±4 beats/min). No exercise was performed on the day before the other OFTT. Fasted (0 h) and postprandial (1, 2, 3, 4, 5 and 6 h) blood samples were taken for analysis of TAG, IL-6 and incretins. Subcutaneous adipose tissue biopsies were taken at 0 and 6 h after OFTT ingestion for IL-6 and GIP receptor (GIPr) mRNA quantification. Exercise lowered fasting and postprandial TAG (P .05). Fasting and postprandial plasma IL-6, GIP and GLP-1 did not differ between rest and exercise OFTT trials (P&gt;.05). Exercise reduced IL-6 and GIPr mRNA (P&lt;.05) in adipose tissue. Our results suggest that the reduction in VLDL TAG following an acute bout of exercise is not associated with circulating IL-6 or incretin concentrations, despite reductions in the adipose tissue expression of IL-6 and GIPr.</description><dc:title>Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men - Corrected Proof</dc:title><dc:creator>Mark J. Dekker, Terry E. Graham, T.C. Ooi, Lindsay E. Robinson</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001776/abstract?rss=yes"><title>Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001776/abstract?rss=yes</link><description>Abstract: Further clarification is needed to address the paradox that memory formation, aging and neurodegeneration all involve calcium influx, oxyradical production (ROS) and activation of certain signaling pathways. In aged rats and in APP/PS-1 mice, cognitive and hippocampal Ca2+ dysregulation was reversed by food supplementation with a high antioxidant blueberry extract. Here, we studied whether neurons were an important target of blueberry extract and whether the mechanism involved altered ROS signaling through MAP kinase and cyclic-AMP response element binding protein (CREB), pathways known to be activated in response to amyloid-beta (Aβ). Primary hippocampal neurons were isolated and cultured from embryonic, middle-age or old-age (24 months) rats. Blueberry extract was found to be equally neuroprotective against Aβ neurotoxicity at all ages. Increases in Aβ toxicity with age were associated with age-related increases in immunoreactivity of neurons to pERK and an age-independent increase in pCREB. Treatment with blueberry extract strongly inhibited these increases in parallel with neuroprotection. Simultaneous labeling for ROS and for glutathione with dichlorofluorescein and monochlorobimane showed a mechanism of action of blueberry extract to involve transient ROS generation with an increase in the redox buffer glutathione. We conclude that the increased age-related susceptibility of old-age neurons to Aβ toxicity may be due to higher levels of activation of pERK and pCREB pathways that can be protected by blueberry extract through inhibition of both these pathways through an ROS stress response. These results suggest that the beneficial effects of blueberry extract may involve transient stress signaling and ROS protection that may translate into improved cognition in aging rats and APP/PS1 mice given blueberry extract.</description><dc:title>Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract - Corrected Proof</dc:title><dc:creator>Gregory J. Brewer, John R. Torricelli, Amanda L. Lindsey, Elizabeth Z. Kunz, A. Neuman, Derek R. Fisher, James A. Joseph</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001788/abstract?rss=yes"><title>High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001788/abstract?rss=yes</link><description>Abstract: Chronic renal failure (CRF) is associated with malnutrition and renal tissue accumulation of lipids, which can contribute to progression of renal disease. This study was designed to explore the effect of a high-calorie diet on pathways involved in lipid metabolism in the remnant kidney of rats with CRF. 5/6 nephrectomized rats were randomized to receive a regular diet (3.0 kcal/g) or a high-calorie diet (4.5 kcal/g) for 12 weeks. Renal lipid contents and abundance of molecules involved in cholesterol and fatty acid metabolism were studied. The CRF group consuming a regular diet exhibited growth retardation; azotemia; proteinuria; glomerulosclerosis; tubulointerstitial injury; heavy lipid accumulation in the remnant kidney; up-regulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), ATP-binding cassette transporter-1 (ABCA1), liver X receptor (LXR) α/β, carbohydrate-responsive element binding protein (ChREBP) and acyl-CoA carboxylase (ACC); and down-regulation of peroxisome proliferator-activated receptor-α (PPAR-α), carnitine palmitoyltransferase-1 (CPT1) and liver-type fatty acid binding protein (L-FABP). The high-calorie diet restored growth; reduced the severity of tubulointerstitial injury, proteinuria and azotemia; partially lowered renal tissue lipid contents; attenuated the up-regulation of mediators of lipid influx (LOX-1), lipid efflux (LXR-α/β and ABCA1) and fatty acid biosynthesis (ChREBP and ACC); and reversed the down-regulation of factors involved in fatty acid oxidation (PPAR-α, CPT1 and L-FABP). In conclusion, a high-calorie diet restores growth, improves renal function and structure, and lowers lipid burden in the remnant kidney. The latter is associated with and most likely due to reduction in lipid influx and enhancement of fatty acid oxidation.</description><dc:title>High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney - Corrected Proof</dc:title><dc:creator>Hyun Ju Kim, Jun Yuan, Keith Norris, Nosratola D. Vaziri</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528630900179X/abstract?rss=yes"><title>A maternal high n-6 fat diet with fish oil supplementation during pregnancy and lactation in rats decreases breast cancer risk in the female offspring - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528630900179X/abstract?rss=yes</link><description>Abstract: The timing of dietary fat intake may modify breast cancer risk. In addition, n-3 fatty acids reduce, and n-6 fatty acids increase, the risk of breast cancer and a maternal high n-6 fat diet results in a greater risk of breast cancer in the female offspring. We hypothesized that the timing of n-3 fatty acid-enriched fish oil supplementation would be important for reducing the risk of breast cancer. Female rats were fed to a high n-6 fat diet containing 20% of the sunflower oil by weight during pregnancy and lactation, and the female offspring were exposed to fish oil by oral gavage either during the perinatal period via maternal intake or during puberty or adulthood. Exposure during the perinatal period to a maternal high n-6 fat diet with fish oil supplementation significantly reduced the incidence of carcinogen-induced mammary tumors in the female offspring compared to a maternal high n-6 fat diet with no fish oil supplementation or fish oil supplementation later in life (P=.0228 by Cox proportional hazards model). We found that a maternal high n-6 fat diet during pregnancy is more important in increasing the risk of mammary tumors in the female offspring than a maternal high n-6 fat diet during lactation. This study suggests that fish oil supplementation during the perinatal period decreases the effect of a maternal high n-6 fat diet on subsequent carcinogen-induced mammary tumor risk, whereas fish oil supplementation during puberty or adulthood does not.</description><dc:title>A maternal high n-6 fat diet with fish oil supplementation during pregnancy and lactation in rats decreases breast cancer risk in the female offspring - Corrected Proof</dc:title><dc:creator>Hui-Min Su, Pei-Hsuan Hsieh, Hui-Feng Chen</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001922/abstract?rss=yes"><title>In vitro and in vivo conjugation of dietary hydroxycinnamic acids by UDP-glucuronosyltransferases and sulfotransferases in humans - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001922/abstract?rss=yes</link><description>Abstract: Hydroxycinnamic acids are a class of phenolic antioxidants found widely in dietary plants. Their biotransformation in the human organism primarily involves Phase II conjugation reactions. In this study, activities of UDP-glucuronosyltransferases (UGTs) and sulfotransferases (SULTs) towards major dietary hydroxycinnamic acids (caffeic, dihydrocaffeic, dihydroferulic, ferulic and isoferulic acids) were investigated. Conjugate formation was evaluated using human liver and intestinal S9 homogenates, and in vitro characterization was carried out using recombinant human UGTs and SULTs. Analysis of the kinetics of hydroxycinnamic acid conjugation in human S9 homogenates revealed that intrinsic clearance (Vmax/Km) is much greater for sulfation than for glucuronidation. Assessment of activity using a panel of recombinant human SULTs showed that SULT1A1 is most active in the sulfation of caffeic, dihydrocaffeic and isoferulic acids, while SULT1E1 is most active in the sulfation of ferulic and dihydroferulic acids. Only isoferulic acid was significantly glucuronidated by human liver S9 homogenates, explained by the high activity of liver-specific UGT1A9. Studies on the kinetics of active SULTs and UGTs demonstrated a markedly lower Km for SULTs. To further corroborate our findings, we carried out an intervention study in healthy humans to determine the hydroxycinnamic acid conjugates in urine after consumption of hydroxycinnamate-rich coffee (200 ml). Analysis showed that sulfates are the main conjugates in urine, with the exception of isoferulic acid, which is mainly glucuronidated. These data suggest that sulfates are the predominant hydroxycinnamic acid conjugates in humans, and that SULT mediated sulfation is a major factor determining the bioavailability of hydroxycinnamic acids in vivo.</description><dc:title>In vitro and in vivo conjugation of dietary hydroxycinnamic acids by UDP-glucuronosyltransferases and sulfotransferases in humans - Corrected Proof</dc:title><dc:creator>Chi Chun Wong, Walter Meinl, Hans-Rudolf Glatt, Denis Barron, Angélique Stalmach, Heike Steiling, Alan Crozier, Gary Williamson</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001934/abstract?rss=yes"><title>Mechanisms of anti-atherosclerotic functions of soy-based diets - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001934/abstract?rss=yes</link><description>Abstract: Soy-based diets have been reported to protect against the development of atherosclerosis. However, the underlying mechanism(s) for this protection remains unknown. Although atherosclerosis was traditionally considered a disease associated with impaired lipid metabolism, in recent years the inflammatory components of atherosclerosis have been explored. Recent studies have convincingly delineated that uncontrolled chronic inflammation is the principal contributing factor for the initiation and progression of atherosclerosis. Interaction between activated monocytes and vascular endothelial cells is an early event in atherogenesis. The adhesion of leukocytes, including monocytes, to the inflamed-vascular endothelium and their transmigration into intima initiate the inflammatory processes. Following transmigration, monocytes in the intima are transformed to macrophages, which take up oxidized-LDL (oxLDL) to generate lipid-laden macrophages, also known as foam cells. Hence, in this review article the inflammatory processes associated with atherosclerosis and possible anti-inflammatory functions of soy-based diets contributing to the prevention of atherosclerosis are presented.</description><dc:title>Mechanisms of anti-atherosclerotic functions of soy-based diets - Corrected Proof</dc:title><dc:creator>Shanmugam Nagarajan</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528630900151X/abstract?rss=yes"><title>Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528630900151X/abstract?rss=yes</link><description>Abstract: A healthy diet and plant sterols (PS) are recommended for reducing low-density lipoprotein (LDL) cholesterol and, subsequently, the risk of premature cardiovascular disease. PS mediate a decrease in fat-soluble vitamin concentration, which can lead to a general impairment of antioxidative defenses and an increase in oxidative stress. Thus, we evaluated the effects of a healthy diet, including PS-enriched low-fat milk, on cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects.This was a randomized parallel trial employing 40 subjects and consisting of two 3-month intervention phases. After 3 months on a standard healthy diet, subjects were divided into two intervention groups: a diet group and a diet+PS group (2 g/day). Lipid profile, apolipoproteins, high-sensitivity C-reactive protein and oxidative stress parameters were analyzed. Diet significantly reduced total and LDL cholesterol (4.0% and 4.7%, respectively), produced an increase in the level of β-carotene (23%) and improved the antioxidant capacity of LDL cholesterol particles (4.6%). PS induced a significant decrease in total cholesterol (6.4%), LDL (9.9%) and the apolipoprotein B100/apolipoprotein A1 ratio (4.9%), but led to a decrease in cryptoxanthin level (29%) without any change being observed in the antioxidant capacity of LDL cholesterol particles, total antioxidant status or lipid peroxidation. After 3 months, we observed the positive effect of including a PS supplement in dietary measures, as the lipoprotein-mediated risk of cardiovascular disease was reduced. Despite a decrease in the concentration of cryptoxanthin, no evidence of a global impairment of antioxidative defenses or an enhancement of oxidative stress parameters was found.</description><dc:title>Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols - Corrected Proof</dc:title><dc:creator>Celia Bañuls, María L. Martínez-Triguero, Antonio López-Ruiz, Carlos Morillas, Ramon Lacomba, Víctor M. Víctor, Milagros Rocha, Antonio Hernández-Mijares</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-11-04</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-11-04</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001405/abstract?rss=yes"><title>Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001405/abstract?rss=yes</link><description>Abstract: Human milk contains biological factors that are involved in a newborn's growth and immune system regulation. By integrating standard biochemical experimental protocols with computational methods, the present study investigates the presence of heme oxygenase-1 (HO-1), a cytoprotective enzyme, in human milk at different levels of maturation and in milk formulae. Furthermore, we evaluated cytokine and glutathione S-transferase (GSH) levels. Samples were collected from colostrum (on Day 1 after birth), from transition milk (on Postdelivery Days 7 and 14) and from mature milk (on Day 30 after delivery) in 14 healthy women. HO-1 protein, GSH and cytokines levels were measured using enzyme-linked immunosorbent assay and flow cytometry. HO-1 protein levels were significantly higher in colostrum (1.33 ng/ml; 5th centile 0.92; 95th centile 2.38) and in transition milk at 14 days (0.97 ng/ml; 5th centile 0.87; 95th centile 1.45) than in mature milk (0.9 ng/ml; 5th centile 0.8; 95th centile 1.38). Levels of HO-1 in milk formulae were similar to those in colostrum. No significant differences in GSH content were observed in mature milk, transition milk and colostrum, whereas significantly higher GSH levels were observed in milk formulae. No significant levels of cytokines, with the exception of interleukin-8, were found. Computational studies on the possible interactions between HO-1 and CD91 were carried out by a battery of softwares, namely, GRAMM (version 1.03), DALI, CLUSTALW (version 2.0), PatchDock and FireDock, mutually counterchecking and validating each other. The computational results, the strong convergence (to the same “solution”) of which finally leads to an “experimental-like” character, showed that HO-1 may bind to CD91, thus suggesting its major role as a new chaperokine in immune response regulation. These findings, which connect and integrate biochemical data and computational data interpretation, represent a synergistic and powerful means of conducting biological research.</description><dc:title>Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach - Corrected Proof</dc:title><dc:creator>Giovanni Li Volti, Fabio Galvano, Alessandro Frigiola, Salvatore Guccione, Claudia Di Giacomo, Stefano Forte, Giovanni Tringali, Massimo Caruso, Olayiwola Adedotun Adekoya, Diego Gazzolo</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-11-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-11-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001508/abstract?rss=yes"><title>Folic acid consumption reduces resistin level and restores blunted acetylcholine-induced aortic relaxation in obese/diabetic mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001508/abstract?rss=yes</link><description>Abstract: Folic acid supplementation provides beneficial effects on endothelial functions in patients with hyperhomocysteinemia. However, its effects on vascular functions under diabetic conditions are largely unknown. Therefore, the effect(s) of folic acid (5.7 and 71 μg/kg/day for 4 weeks) on aortic relaxation was investigated using obese/diabetic (+db/+db) mice and lean littermate (+db/+m) mice. Acetylcholine-induced relaxation in +db/+db mice was less than that observed in +db/+m mice. The reduced relaxation in +db/+db mice was restored by consumption of 71 μg/kg folic acid. Acetylcholine-induced relaxation (with and without folic acid treatment) was sensitive to NG-nitro-l-arginine methyl ester, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one, geldanamycin and triciribine. In addition, acetylcholine-induced relaxation was attenuated by resistin. The plasma level of resistin in +db/+db mice was sevenfold higher than that measured in +db/+m mice, and the elevated plasma level of resistin in +db/+db mice was reduced by 25% after treatment with 71 μg/kg folic acid. Folic acid slightly increased the ratio of reduced glutathione to oxidized glutathione in +db/+db mice. Moreover, folic acid caused a reduction in PTEN (phosphatase and tensin homolog deleted on chromosome 10) expression, an increase in the phosphorylation of endothelial nitric oxide synthase (eNOSSer1177) and AktSer473, and an enhanced interaction of heat shock protein 90 (HSP90) with eNOS in both strains, with greater magnitude observed in +db/+db mice. In conclusion, folic acid consumption improved blunted acetylcholine-induced relaxation in +db/+db mice. The mechanism may be, at least partly, attributed to enhancement of PI3K/HSP90/eNOS/Akt cascade, reduction in plasma resistin level, down-regulation of PTEN and slight modification of oxidative state.</description><dc:title>Folic acid consumption reduces resistin level and restores blunted acetylcholine-induced aortic relaxation in obese/diabetic mice - Corrected Proof</dc:title><dc:creator>Sai Wang Seto, Tsz Yan Lam, Penelope Mei Yu Or, Wayne Yuk Wai Lee, Alice Lai Shan Au, Christina Chui Wa Poon, Rachel Wai Sum Li, Shun Wan Chan, John Hok Keung Yeung, George Pak Heng Leung, Simon Ming Yuen Lee, Sai Ming Ngai, Yiu Wa Kwan</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.015</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-11-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-11-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001521/abstract?rss=yes"><title>Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001521/abstract?rss=yes</link><description>Abstract: The common food additive carrageenan (CGN) predictably induces intestinal inflammation in animal models. Mechanisms of CGN-induced nuclear factor κB and interleukin-8 (IL-8) stimulation include an immune-mediated pathway involving toll-like receptor 4 (TLR4) and B-cell lymphoma/leukemia 10 (BCL10) and a reactive oxygen species (ROS)-mediated pathway. To determine how the structure of CGN contributes to its initiation of inflammation through these two distinct mechanisms, we treated CGNs with galactosidases and carrageenases (CGNases) and determined the impact on IL-8 secretion and BCL10 production. Hydrolysis of CGN by the enzyme α-1→(3,6)-galactosidase significantly reduced increases in IL-8 and BCL10, but other galactosidases tested, including α-1→6-galactosidase, β-1→4-galactosidase and β-1→3,6-galactosidase, had no effect. In contrast, specific κ-CGNases or ι-CGNases, which hydrolyze β-1,4-galactosidic bonds, produced increases in IL-8 and BCL10 attributable to increased exposure of the immunogenic α-1→3-galactosidic epitope of CGN to TLR4. These results were consistent with induction of innate immune response by an interaction of TLR4 with the unusual α-d-Gal-(1→3)-d-Gal epitope present in CGN. Activation of the ROS-mediated pathway was unaffected by treatment of κ-CGN with either κ-CGNase (3 mg/L), α-1→(3,6)-galactosidase (20 mU/ml) or these enzymes in combination, indicating that changes in IL-8 production were attributable to the effects of induction of inflammation on the TLR4–BCL10-mediated innate immune pathway. These findings provide new information about the specificity of carbohydrate–protein interaction between CGN and TLR4 and may help to devise treatments that modify the immune reactivity induced by carbohydrate antigens.</description><dc:title>Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds - Corrected Proof</dc:title><dc:creator>Sumit Bhattacharyya, Haiying Liu, Zhenqing Zhang, Murielle Jam, Pradeep K. Dudeja, Gurvan Michel, Robert J. Linhardt, Joanne K. Tobacman</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-10-30</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-10-30</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001375/abstract?rss=yes"><title>Trans-10, cis-12-conjugated linoleic acid alters hepatic gene expression in a polygenic obese line of mice displaying hepatic lipidosis - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001375/abstract?rss=yes</link><description>Abstract: The trans-10, cis-12 isomer of conjugated linoleic acid (CLA) causes a rapid reduction of body and adipose mass in mice. In addition to changes in adipose tissue, numerous studies have reported alterations in hepatic lipid metabolism. Livers of CLA-fed mice gain mass, partly due to lipid accumulation; however, the precise molecular mechanisms are unknown. To elucidate these mechanisms, we examined fatty acid composition and gene expression profiles of livers from a polygenic obese line of mice fed 1% trans-10, cis-12-CLA for 14 days. Analysis of gene expression data led to the identification of 1393 genes differentially expressed in the liver of CLA-fed male mice at a nominal P value of .01, and 775 were considered significant using a false discovery rate (FDR) threshold of .05. While surprisingly few genes in lipid metabolism were impacted, pathway analysis found that protein kinase A (PKA) and cyclic adenosine monophosphate (cAMP) pathways signaling pathways were affected by CLA treatment and 98 of the 775 genes were found to be regulated by hepatocyte nuclear factor 4α, a transcription factor important in controlling liver metabolic status.</description><dc:title>Trans-10, cis-12-conjugated linoleic acid alters hepatic gene expression in a polygenic obese line of mice displaying hepatic lipidosis - Corrected Proof</dc:title><dc:creator>Melissa S. Ashwell, Ryan P. Ceddia, Ralph L. House, Joseph P. Cassady, Eugene J. Eisen, Thomas E. Eling, Jennifer B. Collins, Sherry F. Grissom, Jack Odle</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.013</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-10-05</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-10-05</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001399/abstract?rss=yes"><title>Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001399/abstract?rss=yes</link><description>Abstract: Phytoestrogens have attracted attention as being safer alternatives to hormone replacement therapy (HRT) and as chemopreventive reagents for breast cancer because dietary soy isoflavone intake has been correlated with reduction in risk. To identify safe and effective phytoestrogen candidates for HRT and breast cancer prevention, we investigated the effects of daidzein, genistein, coumestrol, resveratrol and glycitein on cell growth, cell cycle, cyclin D1 expression, apoptosis, Bcl-2/Bax expression ratio and p53-dependent or NF-κB-dependent transcriptional activity in MCF-7 breast cancer cells. Phytoestrogens, except for glycitein, significantly enhanced estrogen-response-element-dependent transcriptional activity up to a level similar to that of 17β-estradiol (E2). E2 increased cell growth significantly, coumestrol increased cell growth moderately, and resveratrol and glycitein reduced cell growth. Phytoestrogens, except for glycitein, stimulated the promotion of cells to G1/S transition in cell cycle analysis, similar to E2. This stimulation was accompanied by transient up-regulation of cyclin D1. While genistein, resveratrol and glycitein all increased apoptosis and reduced the Bcl-2/Bax ratio, resveratrol reduced this ratio more than either genistein or glycitein. Moreover, resveratrol significantly enhanced p53-dependent transcriptional activity, but slightly reduced NF-κB-dependent transcriptional activity. On knockdown analysis, genistein, resveratrol and glycitein all reduced the Bcl-2/Bax ratio in the presence of apoptosis-inducing stimuli, and estrogen receptor (ER) α silencing had no effect on these reductions. In contrast, in the absence of apoptosis-inducing stimuli, only resveratrol reduced the ratio, and ERα silencing abolished this reduction. Thus, resveratrol might be the most promising candidate for HRT and chemoprevention of breast cancer due to its estrogenic activity and high antitumor activity.</description><dc:title>Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells - Corrected Proof</dc:title><dc:creator>Takako Sakamoto, Hyogo Horiguchi, Etsuko Oguma, Fujio Kayama</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-10-05</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-10-05</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001685/abstract?rss=yes"><title>Effects of dietary fish oil on thyroid hormone signaling in the liver - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001685/abstract?rss=yes</link><description>Abstract: n−3 polyunsaturated fatty acids (PUFAs) present in fish oil (FO) potently decrease serum lipids, which is also an effect of thyroid hormones. Both PUFAs and thyroid hormones affect hepatic lipid metabolism, and here we hypothesized that a long-term diet rich in n−3 PUFAs would enhance thyroid hormone action in the liver. Female rats received isocaloric and normolipid diets containing either soybean oil (SO) or FO during lactation. Male offspring received the same diet as their dams since weaning until sacrifice when they were 11 weeks old. FO group, as compared to SO group, exhibited lower body weight since 5 weeks of age until sacrifice, with no alterations in food ingestion, lower retroperitoneal white fat mass and elevated inguinal fat mass relative to body weight, with unchanged water and lipid but reduced protein percentage in their carcasses. FO diet resulted in lower serum triglycerides and cholesterol. Serum total triiodothyronine, total thyroxine and thyrotropin were similar between groups. However, liver thyroid hormone receptor (TR) β1 protein expression was higher in the FO group and correlated negatively with serum lipids. Liver 5′-deiodinase activity, which converts thyroxine into triiodothyronine, was similar between groups. However, the activity of hepatic mitochondrial glycerophosphate dehydrogenase, the enzyme involved in thermogenesis and a well-characterized target stimulated by T3 via TRβ1, was higher in the FO group, suggesting enhancement of thyroid hormone action. These findings suggest that the increase in thyroid hormone signaling pathways in the liver may be one of the mechanisms by which n−3 PUFAs exert part of their effects on lipid metabolism.</description><dc:title>Effects of dietary fish oil on thyroid hormone signaling in the liver - Corrected Proof</dc:title><dc:creator>Luana L. Souza, Marcio O. Nunes, Gabriela S.M. Paula, Aline Cordeiro, Vânia Penha-Pinto, Jose Firmino N. Neto, Karen J. Oliveira, Maria das Graças Tavares do Carmo, Carmen C. Pazos-Moura</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-09-30</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-09-30</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001211/abstract?rss=yes"><title>Caffeic acid phenethyl ester is a potent inhibitor of HIF prolyl hydroxylase: structural analysis and pharmacological implication - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001211/abstract?rss=yes</link><description>Abstract: Caffeic acid phenethyl ester (CAPE) is an active component of propolis from honeybee. We investigated a potential molecular mechanism underlying a CAPE-mediated protective effect against ischemia/reperfusion (I/R) injury and analyzed the structure contributing to the CAPE effect. CAPE induced hypoxia-inducible factor-1 (HIF-1) α protein, concomitantly transactivating the HIF-1 target genes vascular endothelial growth factor and heme oxygenase-1, which play a protective role in I/R injury. CAPE delayed the degradation of HIF-1α protein in cells, which occurred by inhibition of HIF prolyl hydroxylase (HPH), the key enzyme for von Hippel–Lindau-dependent HIF-1α degradation. CAPE inhibition of HPH and induction of HIF-1α protein were neutralized by an elevated dose of iron. The catechol moiety, a chelating group, is essential for HPH inhibition, while hydrogenation of the double bond (–CC–) in the Michael reaction acceptor markedly reduced potency. Removal of the phenethyl moiety of CAPE (substitution with the methyl moiety) severely deteriorated its inhibitory activity for HPH. Our data suggest that a beneficial effect of CAPE on I/R injury may be ascribed to the activation of HIF-1 pathway via inhibition of HPH and reveal that the chelating moiety of CAPE acted as a pharmacophore while the double bond and phenethyl moiety assisted in inhibiting HPH.</description><dc:title>Caffeic acid phenethyl ester is a potent inhibitor of HIF prolyl hydroxylase: structural analysis and pharmacological implication - Corrected Proof</dc:title><dc:creator>Daekyu Choi, Jeongoh Han, Youna Lee, Jungyun Choi, Songyi Han, Sungchae Hong, Hyunchu Jeon, Young Mi Kim, Yunjin Jung</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-09-10</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-09-10</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001338/abstract?rss=yes"><title>Lipoprotein metabolism mediates the association of MTP polymorphism with β-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001338/abstract?rss=yes</link><description>Abstract: Nonalcoholic steatohepatitis (NASH) predicts incident diabetes independently of insulin resistance, adiposity and metabolic syndrome through unclear mechanisms. Dietary fat consumption and lipoperoxidative stress predispose to diabetes in the general population and to liver injury in NASH. Microsomal triglyceride transfer protein (MTP) polymorphism modulates lipoprotein metabolism in the general population and liver disease in NASH; a functional MTP polymorphism recently predicted incident diabetes independently of insulin resistance in the general population. We simultaneously assessed the impact of MTP polymorphism, diet, adipokines and lipoprotein metabolism, on glucose homeostasis in NASH.MTP −493G/T polymorphism, dietary habits, adipokines and postprandial triglyceride-rich lipoproteins, high-density lipoprotein cholesterol (HDL-C) and oxidized low-density lipoprotein (oxLDL) responses to an oral fat load, were cross-sectionally correlated to oral glucose tolerance test- and frequently sampled intravenous glucose tolerance test-derived Minimal Model indexes of glucose homeostasis in 40 nondiabetic normolipidemic patients with NASH and 40 age-,sex- and body mass index-matched healthy controls.Despite comparable insulin resistance, fasting lipids, adipokines and dietary habits, MTP GG genotype had significantly more severe β-cell dysfunction; higher plasma Tg, FFA, intestinal and hepatic very low-density lipoprotein 1 subfractions and oxLDL responses and deeper HDL-C fall than GT/TT carriers in patients and controls.Postprandial HDL-C and oxLDL responses independently predicted β-cell dysfunction and mediated the effect of MTP polymorphism on β-cell function.In nondiabetic normolipidemic NASH, MTP −493G/T polymorphism modulates β-cell function, an effect mediated by postprandial HDL-C and oxLDL metabolism. The impact of this polymorphism on the risk of diabetes and the efficacy of lipid-lowering therapies in restoring β-cell function in NASH, even with normal fasting lipid values, warrant further investigation.</description><dc:title>Lipoprotein metabolism mediates the association of MTP polymorphism with β-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis - Corrected Proof</dc:title><dc:creator>Giovanni Musso, Roberto Gambino, Maurizio Cassader</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-09-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-09-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001314/abstract?rss=yes"><title>4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001314/abstract?rss=yes</link><description>Abstract: The effects of polyunsaturated fatty acids (PUFAs) obtained from the diet on colorectal cancer have been widely explored. However, controversial results have been obtained about the role played by the lipid peroxidation products of PUFAs, such as 4-hydroxy-nonenal (HNE), in the control of colon cancer growth. This aldehyde, indeed, showed both procarcinogenic and protective effects. In an attempt to verify the action of HNE, we studied the effects of a low dose of HNE (1 μM), similar to those “physiologically” found in normal cells and plasma, on telomerase activity, a key parameter of malignant transformation. Caco-2 cells were exposed to HNE and, paralleling cell growth inhibition, we observed the down-regulation of telomerase activity and hTERT expression. Similar effects have also been observed in HT-29 cells, in which HNE inhibited cell proliferation, telomerase activity and hTERT expression, suggesting that the inhibition of telomerase activity could be a general mechanism involved in the antiproliferative effect exerted by this aldehyde. Finally, we elucidated the mechanism of hTERT inhibition by HNE. A reduction of GSH content preceded the decrease of telomerase activity, but this only partially explained the telomerase activity inhibition. The major mechanism of HNE action seems to be the modulation of expression and activity of transcription factors belonging to the Myc/Mad/Max network.Since the presence of PUFAs in the diet exposes epithelial colon cells to HNE, this aldehyde could contribute to cell growth control through the inhibitory action on telomerase activity and hTERT expression, suggesting a protective effect on colon mucosa.</description><dc:title>4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity - Corrected Proof</dc:title><dc:creator>Stefania Pizzimenti, Elisa Menegatti, Daniela Berardi, Cristina Toaldo, Piergiorgio Pettazzoni, Rosalba Minelli, Barbara Giglioni, Angelo Cerbone, Mario U. Dianzani, Carlo Ferretti, Giuseppina Barrera</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-09-04</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-09-04</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309000862/abstract?rss=yes"><title>β-Glucan extracts inhibit the in vitro intestinal uptake of long-chain fatty acids and cholesterol and down-regulate genes involved in lipogenesis and lipid transport in rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309000862/abstract?rss=yes</link><description>Abstract: Background: Dietary fiber reduces the intestinal absorption of nutrients and the blood concentrations of cholesterol and triglycerides.Aim: We wished to test the hypothesis that high-viscosity (HV) and low-viscosity preparations of barley and oat β-glucan modify the expression of selected genes of lipid-binding proteins in the intestinal mucosa and reduce the intestinal in vitro uptake of lipids.Methods: Five different β-glucan extracts were separately added to test solutions at concentrations of 0.1–0.5% (wt/wt), and the in vitro intestinal uptake of lipids into the intestine of rats was assessed. An intestinal cell line was used to determine the effect of β-glucan extracts on the expression of intestinal genes involved in lipid metabolism and fatty acid transport.Results: All extracts reduced the uptake of 18:2 when the effective resistance of the unstirred water layer was high. When the unstirred layer resistance was low, the HV oat β-glucan extract reduced jejunal 18:2 uptake, while most extracts reduced ileal 18:2 uptake. Ileal 18:0 uptake was reduced by the HV barley extract, while both jejunal and ileal cholesterol uptakes were reduced by the medium-purity HV barley extract. The inhibitory effect of HV barley β-glucan on 18:0 and 18:2 uptake was more pronounced at higher fatty acid concentrations. The expression of genes involved in fatty acid synthesis and cholesterol metabolism was down-regulated with the HV β-glucan extracts. β-Glucan extracts also reduced intestinal fatty-acid-binding protein and fatty acid transport protein 4 mRNA.Conclusions: The reduced intestinal fatty acid uptake observed with β-glucan is associated with inhibition of genes regulating intestinal uptake and synthesis of lipids. The inhibitory effect of β-glucan on intestinal lipid uptake raises the possibility of their selective use to reduce their intestinal absorption.</description><dc:title>β-Glucan extracts inhibit the in vitro intestinal uptake of long-chain fatty acids and cholesterol and down-regulate genes involved in lipogenesis and lipid transport in rats - Corrected Proof</dc:title><dc:creator>Laurie A. Drozdowski, Raylene A. Reimer, Feral Temelli, Rhonda C. Bell, Thava Vasanthan, Alan B.R. Thomson</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.04.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-08-28</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-08-28</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001156/abstract?rss=yes"><title>Depleted folate pool and dysfunctional mitochondria associated with defective mitochondrial folate proteins sensitize Chinese ovary cell mutants to tert-butylhydroperoxide-induced oxidative stress and apoptosis - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001156/abstract?rss=yes</link><description>Abstract: The functional role of mitochondrial (mt) folate-associated proteins in mammalian cells is not clearly understood. We investigated the respiratory function and apoptosis phenotype of Chinese hamster ovary (CHO) mutant cells with defective mt serine hydroxymethyltransferase (SHMT) activities (glyA) or with defective mt folate transporter (glyB) in the absence/presence of oxidant challenge. The mechanisms underlying their aberrant phenotypes were explored. Compared with CHOK1 wild-type cells, both mutants carried dysfunctional mitochondria with reduced respiratory complex IV activity and depolarized mt membrane potential (P&lt;.05). Elevated superoxide levels and accumulated mtDNA large deletions were observed in glyB in association with a depleted compartmental folate pool (P&lt;.05). tert-Butylhydroperoxide (tBH) treatment at 50 μM for 72 h significantly depleted mt and cytosolic folate levels, impaired antioxidant defenses, and aggravated mt oxidative dysfunction in both mutants (P&lt;.05), more severely in glyB. Only tBH-treated glyB cells displayed an elevated ratio of mt Bax/Bcl-2, activation of procaspases 9 and 3, and apoptosis promotion. The apoptotic phenotype of tBH-treated glyB could be partially corrected by folate supplementation (10–1000 μM), which enriched compartmental folate levels, restored antioxidant defenses, eliminated mt oxidative injuries, and normalized mt membrane function. Our data identify previously unrecognized roles of mt folate-associated proteins in the protection of mitochondria against oxidative insults. Defective mt folate transporter sensitized glyB cells to elevated oxidative stress and tBH-induced apoptosis, partly mediated by depleted compartmental folate and mt dysfunction. Defective mt SHMT sensitized glyA to respiratory dysfunction and tBH-induced oxidative injury without apoptosis promotion.</description><dc:title>Depleted folate pool and dysfunctional mitochondria associated with defective mitochondrial folate proteins sensitize Chinese ovary cell mutants to tert-butylhydroperoxide-induced oxidative stress and apoptosis - Corrected Proof</dc:title><dc:creator>Yi-Ling Ye, Ya-Tsun Chan, Hsiu-Chuan Liu, Hsin-Te Lu, Rwei-Fen S. Huang</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.05.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-08-28</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-08-28</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001181/abstract?rss=yes"><title>Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1α - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001181/abstract?rss=yes</link><description>Abstract: Benign prostatic hyperplasia (BPH) is a disease that impairs the well-being of many aged men. To alleviate BPH symptoms or to find a cure for this disease, key molecules should be identified that control prostate cell proliferation. Recently, HIF-1α has attracted attention in this context, because it is highly expressed in hyperplasic prostates and prevents prostate cell death. Thus, given that vitamin C inhibits HIF-1α expression in several malignant tumors, we examined its therapeutic potential in BPH. HIF-1α was noticeably induced by testosterone in prostate cells, and this HIF-1α induction was abolished by vitamin C. Vascular endothelial growth factor (VEGF) promoter activity reporter assays and semi-quantitative RT-PCR revealed that vitamin C inhibited HIF-1-dependent VEGF expression. Furthermore, HIF-1α suppression by vitamin C was rescued by knocking down HIF-prolyl hydroxylase-2, suggesting that vitamin C destabilizes HIF-1α via prolyl hydroxylation. Moreover, vitamin C treatment abolished cell proliferation induced by testosterone treatment to the control level. These results suggest that vitamin C inhibits testosterone-induced HIF-1α expression and by so doing effectively prevents prostate hyperplasia. In male rats, testosterone treatment for 4 weeks induced prostate hyperplasia. Furthermore, HIF-1α and VEGF levels were significantly elevated in hyperplasic prostates. In vitamin C-treated rats, however, most prostate hyperplasia parameters and prostrate HIF-1α/VEGF levels were markedly reduced. Accordingly, our findings indicate that vitamin C could be further developed clinically for use as an anti-BPH agent.</description><dc:title>Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1α - Corrected Proof</dc:title><dc:creator>Shan-Hua Li, Ji-Hye Ryu, Sook-Eun Park, Young-Suk Cho, Jong-Wan Park, Wang-Jae Lee, Yang-Sook Chun</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-08-28</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-08-28</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309000898/abstract?rss=yes"><title>Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309000898/abstract?rss=yes</link><description>Abstract: CXC chemokine ligand 10 (CXCL10) plays a pivotal role in the recruitment of Th1 cells and, thus, in the development of periodontal disease. Epigallocatechin gallate (EGCG) and epicatechin gallate (ECG), the major catechins derived from green tea, have multiple beneficial effects, but the effects of catechins on CXCL10 production from human gingival fibroblasts (HGFs) is not known. In this study, we investigated the mechanisms by which EGCG and ECG inhibit oncostatin M (OSM)-induced CXCL10 production in HGFs. HGFs constitutively expressed glycoprotein 130 and OSM receptor beta (OSMRβ), which are OSM receptors. OSM increased CXCL10 production in a concentration-dependent manner. EGCG and ECG prevented OSM-mediated CXCL10 production by HGFs. Inhibitors of p38 mitogen-activated protein kinase, c-Jun N-terminal kinase (JNK), phosphatidylinositol-3-OH kinase and signal transducer and activator of transcription (STAT)3 decreased OSM-induced CXCL10 production. EGCG significantly prevented OSM-induced phosphorylation of JNK, Akt (Ser473) and STAT3 (Tyr705 and Ser727). ECG prevented phosphorylation of JNK and Akt (Ser473). In addition, EGCG and ECG attenuated OSMRβ expression on HGFs. These data provide a novel mechanism through which the green tea flavonoids, catechins, can provide direct benefits in periodontal disease.</description><dc:title>Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts - Corrected Proof</dc:title><dc:creator>Yoshitaka Hosokawa, Ikuko Hosokawa, Kazumi Ozaki, Tadashi Nakanishi, Hideaki Nakae, Takashi Matsuo</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.04.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-07-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-07-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309000989/abstract?rss=yes"><title>Suppression of retinoic acid receptors may contribute to embryonic skeleton hypoplasia in maternal rats with chronic vitamin A deficiency - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309000989/abstract?rss=yes</link><description>Abstract: Vitamin A (VA) is essential for embryonic development and the retinoic acid receptors (RARs) are crucial in mediating the diverse actions of VA in embryogenesis. However, the association between RARs and teratogenicity on skeleton growth and development of vitamin A deficiency (VAD) is not clear. In this present study, weaning female Sprague–Dawley rats were fed purified diets containing graded levels of VA (0, 0.4, 4 IU/g diet) for 70 days before mating, and some of them were supplemented with VA (10 IU/g diet) through pregnancy. Embryos were recovered at embryonic day 19.5 (E19.5) for the analysis of skeleton growth and development and the E12.5 embryos were collected for analysis of select mRNA of RARα, RARβ, RARγ, Hoxa2, Hoxa5 and Hoxa9. Normal gene expressions and morphogenesis were observed in all embryos from group fed 4 IU/g diet. The embryos from group fed VA-free diet showed a comprehensive suppression of all the genes and general fetal resorption. The embryos from group fed 0.4 IU/g diet exhibited a moderate down-regulation on RARβ, RARγ, Hoxa2 and Hoxa5, and the E19.5 fetuses displayed a series of skeletal hypoplasia. The VA supplement groups fed 10 IU/g diet displayed normal gene expressions and morphologic appearances. These findings suggested that the suppression of RARs resulted from VAD could disturb the proper expression of homeobox genes, which might, at least in part, contribute to the embryonic skeletal hypoplasia due to maternal rats with chronic VAD.</description><dc:title>Suppression of retinoic acid receptors may contribute to embryonic skeleton hypoplasia in maternal rats with chronic vitamin A deficiency - Corrected Proof</dc:title><dc:creator>Na Li, Shanshan Sun, Di Wang, Ping Yao, Xuefeng Yang, Hong Yan, Yukai Du, Chengjiang Ying, Liegang Liu</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.04.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-07-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-07-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309000990/abstract?rss=yes"><title>Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309000990/abstract?rss=yes</link><description>Abstract: Whether the beneficial effects of pomegranate are due to the ellagitannins or to their microbiota-derived urolithins is not known. Our objectives were to evaluate the effects of pomegranate intake and its main microbiota-derived metabolite urolithin-A (UROA) on colon inflammation and to assess whether UROA is the main anti-inflammatory compound. In addition, the effect of the inflammation on the phenolic metabolism was also explored. Male Fisher rats were fed with 250 mg kg−1 day−1 pomegranate extract (PE) or 15 mg kg−1 day−1 UROA for 25 days. Dextran sodium sulfate (5%) (DSS) was administered for the five last days and then rats were euthanized. DSS is a well-known model of inflammatory bowel disease. Colon tissue damage, microbiota changes, antioxidant status, prostaglandin E2 (PGE2), nitric oxide production, inducible nitric oxide synthase (iNOS), prostaglandin E synthase (PTGES), gene expression (microarrays and RT-PCR) and polyphenol metabolism (LC-MS-MS) were evaluated. Both PE and UROA decreased inflammation markers (iNOS, cycloxygenase-2, PTGES and PGE2 in colonic mucosa) and modulated favorably the gut microbiota. The G1 to S cell cycle pathway was up-regulated in both groups. UROA group showed various down-regulated pathways, including that of the inflammatory response. PE, but not UROA, decreased oxidative stress in plasma and colon mucosa. Only UROA preserved colonic architecture. The normal formation of urolithins in PE-fed rats was prevented during inflammation. Our results suggest that UROA could be the most active anti-inflammatory compound derived from pomegranate ingestion in healthy subjects, whereas in colon inflammation, the effects could be due to the nonmetabolized ellagitannin-related fraction.</description><dc:title>Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism - Corrected Proof</dc:title><dc:creator>Mar Larrosa, Antonio González-Sarrías, María J. Yáñez-Gascón, María V. Selma, María Azorín-Ortuño, Simona Toti, Francisco Tomás-Barberán, Piero Dolara, Juan Carlos Espín</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.04.012</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-07-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-07-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001004/abstract?rss=yes"><title>Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001004/abstract?rss=yes</link><description>Abstract: Pancreatic amyloid deposits of amylin are a hallmark of Type II diabetes and considerable evidence indicates that amylin oligomers are cytotoxic to β-cells. Many efforts are presently spent to find out naturally occurring molecules, or to design synthetic ones, able to hinder amylin aggregation or to protect cells against aggregate cytotoxicity. In this context, a protective effect of some polyphenols against amyloid cytotoxicity was reported. Actually dietary polyphenols are endowed with multiple health benefits, and extra virgin olive oil is attracting increasing interest as a source of these substances. Here, we investigated the effects on amylin aggregation and cytotoxicity of the secoiridoid oleuropein aglycon, the main phenolic component of extra virgin olive oil. We found that oleuropein, when present during the aggregation of amylin, consistently prevented its cytotoxicity to RIN-5F pancreatic β-cells, as determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide test and caspase-3 activity assay. A lack of interaction with the cell membrane of amylin aggregates grown in the presence of oleuropein was shown by fluorescence microscopy and synthetic lipid vesicle permeabilization. Moreover, our ThT assay, circular dichroism analysis and electron microscopy images suggested that oleuropein interferes with amylin aggregation, resulting in a different path skipping the formation of toxic pre-fibrillar aggregates. These results provide a molecular basis for some of the benefits potentially coming from extra virgin olive oil consumption and pave the way to further studies on the possible pharmacological use of oleuropein to prevent or to slow down the progression of type II diabetes.</description><dc:title>Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin - Corrected Proof</dc:title><dc:creator>Stefania Rigacci, Valentina Guidotti, Monica Bucciantini, Matteo Parri, Chiara Nediani, Elisabetta Cerbai, Massimo Stefani, Andrea Berti</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.04.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-07-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-07-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001041/abstract?rss=yes"><title>The role of epoxidation and electrophile-responsive element-regulated gene transcription in the potentially beneficial and harmful effects of the coffee components cafestol and kahweol - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001041/abstract?rss=yes</link><description>Abstract: Cafestol and kahweol are diterpene compounds present in unfiltered coffees. Cafestol is known as the most potent cholesterol-raising agent that may be present in the human diet. Remarkably, the mechanisms behind this effect have only been partly resolved so far. Even less is known about the metabolic fate of cafestol and kahweol. From the structure of cafestol, carrying a furan moiety, we hypothesized that epoxidation may not only be an important biotransformation route but that this also plays a role in its effects found. In bile duct-cannulated mice, dosed with cafestol, we were able to demonstrate the presence of epoxy-glutathione (GSH) conjugates, GSH conjugates and glucuronide conjugates. In addition, it was shown that cafestol was able to induce an electrophile-responsive element (EpRE). Using a murine hepatoma cell line with a luciferase reporter gene under control of an EpRE from the human NQO1 regulatory region, we also found that metabolic activation by CYP450 enzymes is needed for EpRE induction. Furthermore, raising intracellular GSH resulted in a decrease in EpRE-mediated gene induction, whereas lowering intracellular GSH levels increased EpRE-mediated gene induction. In conclusion, evidence suggests that cafestol induces EpRE, apparently via a bioactivation process that possibly involves epoxidation of the furan ring. The epoxides themselves appear subject to conjugation with GSH. The effects on EpRE can also explain the induction of GSH which seems to be involved in the reported beneficial effects of cafestol, for example, when administered with aflatoxin B1 or other toxic or carcinogenic compounds.</description><dc:title>The role of epoxidation and electrophile-responsive element-regulated gene transcription in the potentially beneficial and harmful effects of the coffee components cafestol and kahweol - Corrected Proof</dc:title><dc:creator>Saskia T.J. van Cruchten, Laura H.J. de Haan, Patrick P.J. Mulder, Cindy Kunne, Mark V. Boekschoten, Martijn B. Katan, Jac M.M.J.G. Aarts, Renger F. Witkamp</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.05.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-07-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-07-21</prism:publicationDate></item></rdf:RDF>